7155 Overall survival among metastatic renal cell carcinoma (MRCC) patients corrected for crossover using a rank preserving structural failure time (RPSFT) model: analyses from the everolimus phase III trial

✍ Scribed by Korhonen, P.; Haas, T.; Zuber, E.; Kay, A.; Lebwohl, D.; Motzer, R.

• Book ID: 123102995
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 48 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71488-0